Rheumatoid arthritis in Burkina Faso: clinical and serological profiles

• Published in: Clinical rheumatology Vol. 30; no. 12; pp. 1617 - 1621
• Main Authors: Ouédraogo, Dieu-Donné, Singbo, Joseph, Diallo, Ousséini, Sawadogo, Serge Aimé, Tiéno, Hervé, Drabo, Youssouf Joseph
• Format: Journal Article
• Language: English
• Published: London Springer-Verlag 01.12.2011; Springer Nature B.V
• Subjects: Adult; Aged; Antirheumatic Agents - therapeutic use; Arthritis, Rheumatoid - drug therapy; Arthritis, Rheumatoid - epidemiology; Arthritis, Rheumatoid - immunology; Autoantibodies - blood; Blood Sedimentation; Brief Report; Burkina Faso - epidemiology; C-Reactive Protein - analysis; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Medicine; Medicine & Public Health; Middle Aged; Peptides, Cyclic - immunology; Rheumatoid Factor - immunology; Rheumatology; Severity of Illness Index; Burkina Faso; Sub-saharan africa; Burkina faso; ACPA; Rheumatoid arthritis
• ISSN: 0770-3198; 1434-9949
• DOI: 10.1007/s10067-011-1831-1

The objective of this work was to study the clinical and serological profiles of rheumatoid arthritis in Burkina Faso (West Africa). It is a cross-sectional study conducted from March 2006 to February 2009 in the Internal Medicine Department of the University Hospital Yalgado Ouedraogo. All patients seen in the rheumatologic consultation unit during this period, with rheumatoid arthritis fulfilling the ACR criteria, were routinely selected. The determination of anticyclic citrullinated peptide antibodies (ACPA) was carried out with a computerized method (Elia CCP, Phadia AB, Uppsala, Sweden). Values higher than 10 IU/l were considered positive. Forty-eight cases of rheumatoid arthritis (RA) were recruited throughout the study period among 2,194 (2.2 %) patients. Forty-two files were subjected to the study. There were 34 women and 8 men. The average age was 41.70 ± 13 years with extremes of 22 and 71 years. The average duration of the disease was 86.17 ± 82.01 months with extremes of 8 and 360 months. Rheumatoid factors (RF) were positive in 21 out of 30 patients (70.0%). The determination of ACPA carried out in all the patients was positive in 34 (81%) patients; their average value was 217 IU/l with extremes of 38 and 1,170. RF and ACPA were associated to bones erosions ( p  = 0.0001). Twenty-two patients were placed on methotrexate, eight on hydroxychloroquine, and three on salazopyrine. Nine were given only NSAIDs or prednisolone. No patients had had a biotherapy agent. The frequency of RA was low in our study compared to other African studies published so far. The particularity of RA cases reported in African series, including ours, is the rarity of extra-articular manifestations of the disease. The severity of the disease at presentation in the rheumatology clinic may be due to their late consultation among other causes.